Researchers use iPS cells to produce hematopoietic stem cells

05/16/2013 | Mainichi (Japan), The

Researchers in Japan said they were able to create hematopoietic stem cells from induced pluripotent stem cells. The method involved inducing benign tumors in mice using iPS cells and then adding catalysts to trigger the formation of blood-producing stem cells. The team hopes to develop a method for creating cells that does not rely on the use of tumors.

View Full Article in:

Mainichi (Japan), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA